We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-1.15%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$517M
AUM Growth
+$15.9M
Cap. Flow
+$23.5M
Cap. Flow %
4.53%
Top 10 Hldgs %
36.73%
Holding
119
New
4
Increased
32
Reduced
57
Closed
5

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$7.25M
2
GE icon
GE Aerospace
GE
+$7.12M
3
XOM icon
ExxonMobil
XOM
+$6.33M
4
BCE icon
BCE
BCE
+$2.73M
5
SLB icon
SLB Ltd
SLB
+$2.21M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$7.67M
2
JNJ icon
Johnson & Johnson
JNJ
+$2.51M
3
ABT icon
Abbott
ABT
+$2.33M
4
HDNG
Hardinge Inc
HDNG
+$1.67M
5
TEL icon
TE Connectivity
TEL
+$1.59M

Sector Composition

Rank Sector Weight
1 Healthcare 23.04%
2 Industrials 20.82%
3 Technology 18.73%
4 Energy 10.11%
5 Utilities 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
76
Vanguard S&P 500 ETF
VOO
$993B
$701K 0.14%
2,894
+337
+13% +$84.6K
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.1T
$603K 0.12%
3,025
BLK icon
78
Blackrock
BLK
$169B
$542K 0.1%
1,000
DHR icon
79
Danaher
DHR
$137B
$510K 0.1%
5,880
TSM icon
80
TSMC
TSM
$2.1T
$464K 0.09%
10,600
MU icon
81
Micron Technology
MU
$930B
$454K 0.09%
8,700
+100
+1% +$4.79K
LH icon
82
Labcorp
LH
$25B
$452K 0.09%
3,250
MON
83
DELISTED
Monsanto Co
MON
$444K 0.09%
3,802
+502
+15% +$60.4K
PEP icon
84
PepsiCo
PEP
$190B
$441K 0.09%
4,043
-86
-2% -$9.78K
PSX icon
85
Phillips 66
PSX
$84.9B
$440K 0.09%
4,585
CI icon
86
Cigna
CI
$73.7B
$403K 0.08%
2,400
RDS.A
87
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$398K 0.08%
6,243
-50
-0.8% -$3.29K
GM icon
88
General Motors
GM
$78B
$380K 0.07%
10,450
-1,000
-9% -$40.6K
KO icon
89
Coca-Cola
KO
$377B
$378K 0.07%
8,706
-1,100
-11% -$49.4K
T icon
90
AT&T
T
$159B
$371K 0.07%
13,788
DIS icon
91
Walt Disney
DIS
$167B
$367K 0.07%
3,656
-50
-1% -$5.31K
CELG
92
DELISTED
Celgene Corp
CELG
$358K 0.07%
4,008
IQV icon
93
IQVIA
IQV
$38.7B
$353K 0.07%
3,600
SHW icon
94
Sherwin-Williams
SHW
$82.7B
$326K 0.06%
2,493
+786
+46% +$107K
REGN icon
95
Regeneron Pharmaceuticals
REGN
$78.5B
$310K 0.06%
900
OCLR
96
DELISTED
Oclaro Inc.
OCLR
$305K 0.06%
31,900
-700
-2% -$5.25K
COHR icon
97
Coherent
COHR
$51.4B
$278K 0.05%
6,800
-4,000
-37% -$173K
JCI icon
98
Johnson Controls International
JCI
$88.8B
$271K 0.05%
7,681
-50
-0.6% -$1.9K
EEM icon
99
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$266K 0.05%
5,500
-125
-2% -$6.13K
QQQ icon
100
Invesco QQQ Trust
QQQ
$469B
$260K 0.05%
+1,624
New +$268K

Similar funds

John G. Ullman & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, John G. Ullman & Associates held 119 positions worth $517M, up 3.2% from $501M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

John G. Ullman & Associates deployed $23.5M of net new capital in Q1 2018, opening 4 new positions and adding to 32 existing holdings. Its largest new stake was Halliburton: 34,800 shares worth $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $7.67M trimmed.

  • John G. Ullman & Associates's largest Q1 2018 buy was Halliburton: 34,800 shares worth $1.63M.
  • John G. Ullman & Associates added most to Procter & Gamble in Q1 2018, an estimated $7.25M increase.
  • John G. Ullman & Associates's biggest Q1 2018 reduction was ConocoPhillips, cutting an estimated $7.67M.
  • John G. Ullman & Associates fully exited State Street Utilities Select Sector SPDR ETF in Q1 2018, selling an estimated $527K.
  • John G. Ullman & Associates's ten largest holdings make up 37% of its $517M portfolio in Q1 2018.
  • John G. Ullman & Associates opened 4 new positions and closed 5 in Q1 2018.
  • John G. Ullman & Associates's portfolio value rose 3.2% quarter-over-quarter to $517M.

Based on John G. Ullman & Associates's 13F filing for Q1 2018, filed 19 Apr 2018.